FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for prevention of candidal lesions of digestive tract in treatment of patients with ulcerative colitis (UC), who obtain glucocorticosteroid (GCS) therapy. Therapy with glucocorticosteroids and 5-aminosalicilic acid preparations is carried out. Additionally administered is preparation "Vitaflor", intake per os in dose 1 capsule, covered with intestinally soluble coating, two times per day during entire treatment period.
EFFECT: invention makes it possible to suppress excessive growth of fungi of genus Candida in large intestine and prevent candidal lesion of mucous membrane of digestive tract in patients with UC, obtaining GCS therapy.
3 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RECTAL APPLICATION OF OZONE IN A MODEL OF ULCERATIVE COLITIS | 2022 |
|
RU2787973C1 |
METHOD FOR INTRAPERITONEAL APPLICATION OF MEDICAL OZONE FOR TREATING ULCERATIVE COLITIS | 2021 |
|
RU2782488C1 |
METHOD OF TREATING ULCEROUS DISEASE OF DUODENUM IN CHILDREN, ASSOCIATED WITH FUNGUS OF GENUS Candida | 2009 |
|
RU2416405C1 |
ANTIFUNGAL THERAPEUTIC PREPARATION IN SUPPOSITORIES FOR CHILDREN | 2013 |
|
RU2535068C1 |
METHOD OF STOMACH ULCER TREATMENT | 2006 |
|
RU2329810C1 |
METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN ULCERATIVE COLITIS | 2012 |
|
RU2504779C1 |
AGENT FOR TREATING ORAL CANDIDIASIS | 2021 |
|
RU2780094C1 |
KOBITOLIMOD FOR USE IN TREATMENT OF INFLAMMATORY BOWEL DISEASE | 2018 |
|
RU2766356C2 |
METHOD OF TREATING CHRONIC RECURRENT VULVOVAGINITIS | 2009 |
|
RU2423978C1 |
METHOD FOR TREATING INTESTINAL DISBIOSIS AT INCREASED PROLIFERATION OF CANDIDA- TYPE FUNGI | 2001 |
|
RU2200039C2 |
Authors
Dates
2011-05-27—Published
2009-12-08—Filed